Since renal cell carcinoma is a component cancer of Cowden syndrome and KLLN is a known cancer predisposition marker for CS/CSL patients, we used the renal cell carcinoma data as a surrogate to identify the KLLN-TRIM25-MDM2 axis in the regulation of protein degradation. This evidence concerns the gene MDM2 and hereditary clear cell renal cell carcinoma.